Skip to main content
. 2017 May 23;14(1):885–890. doi: 10.3892/ol.2017.6231

Figure 1.

Figure 1.

Kaplan-Meier plots of the (A) progression-free survival and (B) overall survival in patients with (EGFR) mutations in the tumor vs. patients with wild-type EGFR in the tumor. EGFR, epidermal growth factor receptor; bold line, EGFR mutation group; dashed line, EGFR wild type.